-
-
7 . Periodical
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
- 저자
- by Mosenzon, Ofri; Blicher, Thalia Marie; Rosenlund, Signe; Eriksson, Jan W; Heller, Simon, et al.
- 소스
- The Lancet Diabetes & Endocrinology; July 2019, Vol. 7 Issue: 7 p515-527, 13p